Agenda & Speakers Slides

Day 1: Agenda & Speakers Slides
Day 2: Agenda & Speaker Slides
Print Agenda (PDF)

Thursday, October 24

8:15 – 8:50 AM 

Registration and Continental Breakfast

8:50 – 9:00 AM 

Welcome and Opening Remarks
Amy Comstock Rick
, President & CEO, Food and Drug Law Institute

9:00 – 9:45 AM 

Mitchell Zeller, Director of FDA’s Center for Tobacco Products (CTP), will provide updates on key aspects of FDA’s comprehensive plan for tobacco and nicotine regulation, including the agency’s nicotine policies and science-based review of tobacco products. Director Zeller will also highlight key efforts of the agency’s youth tobacco prevention plan, including the latest actions to prevent youth access to tobacco products, curb marketing of tobacco products aimed at youth, and educate teens about the dangers of using any tobacco product (including e-cigarettes).

Mitchell R. Zeller, Director, Center for Tobacco Products (CTP), FDA

9:45 – 10:45 AM

In this session, panelists will discuss Director Zeller’s comments on FDA’s comprehensive plan for tobacco and nicotine reduction, FDA efforts to prevent youth tobacco and nicotine product use, and address other current policy initiatives.

David Dobbins, Chief Operating Officer, Government Affairs, Truth Initiative
Moira Gilchrist, Vice President, Scientific and Public Communications, Philip Morris International
Kathleen Hoke, Director, Legal Resource Center for Public Health and Policy, University of Maryland Carey School of Law
Moderated by Dean Cirotta, President and COO, EAS Consulting Group 

10:45 – 11:15 AM

Networking and Refreshment Break

11:15 AM – 12:15 PM 

In this session, panelists with diverse perspectives will take a broad look at how the relative risks of tobacco and nicotine products should be communicated to adults. The discussion will include the roles of government, public health, and industry; ways to communicate beyond public education campaigns; and how to coordinate messaging across all stakeholders. Barriers to communication and the impact on consumers and the public will also be discussed.

Marissa G. Hall, Assistant Professor, Department of Health Behavior, University of North Carolina Gillings School of Public Health
Cheryl Healton, Dean, New York University College of Global Public Health
Mitchell A. Neuhauser, Vice President and Assistant General Counsel, RAI Services Company (RAISC)
Moderated by Stacy L. Ehrlich, Partner, Kleinfeld, Kaplan & Becker LLP, Member, FDLI Board of Directors

12:15 – 1:15 PM

Luncheon with Guest Speaker

Thomas J. Miller, Attorney General, Iowa
Introduced by Laura Brown, Director of Educational Programs, FDLI

1:15 – 1:30 PM

Transition

1:30 – 2:30 PM 

We can all agree that youth should not begin using e-cigarettes or other Electronic Nicotine Delivery Systems (ENDS). In this session, panelists will review recent youth vaping statistics and current FDA efforts to combat youth use, then turn to a discussion of what roles public health, industry, retailers, schools, law enforcement, and technological solutions can and should play in such efforts in the future, including the Trump Administration’s proposed ban on all non-tobacco flavors for e-cigarettes.

David Abrams, Professor of Social and Behavioral Sciences, New York University College of Global Public Health
James Baumberger, Senior Director, Federal Advocacy, American Academy of Pediatrics
Parker David Kasmer, Regulatory Counsel, JUUL Labs
Moderated by J. Benneville (Ben) Haas, Partner, Latham & Watkins LLP

2:30 – 3:30 PM 

In this session, panelists will discuss how modified risk tobacco products (MRTPs) should be marketed and advertised to adults, considering both their value as alternative to combustible products and the interest in preventing youth use. Panelists will discuss FDA’s perspective on modified risk claims, the potential value of these claims, the information and misinformation being shared via marketing channels, and offer industry’s perspective on how modified risk product claims should be approached.

Aruni Bhatnagar, Chair, School of Medicine, University of Louisville and co-Director, American Heart Association Tobacco Center for Regulatory Science
Cynthia Cabrera, President, The Cating Group
Brittani Cushman, Senior Vice President, External Affairs, Turning Point Brands, Inc.
Moderated by Bryan M. Haynes, Partner, Troutman Sanders LLP

3:30 – 4:00 PM 

Networking and Refreshment Break

4:00 – 5:00 PM

An important part of FDA’s Comprehensive Plan for Tobacco and Nicotine Regulation to reduce smoking is limiting nicotine in combustible tobacco products to minimally or non-addictive levels. In this session, panelists will review research on Very Low Nicotine Content (VLNC) products, discuss what an ideal nicotine product standard would like, and predict what legal or other challenges may arise in implementing such a rule.

Jonathan Foulds, Professor of Public Health Sciences and Psychiatry, Penn State University College of Medicine
Stacey Gagosian, Managing Director, Public Policy, Truth Initiative
John D. Pritchard, Vice President of Regulatory Science, 22nd Century Group
Moderated by Robyn Gougelet, Senior Associate, Pinney Associates, Inc.

5:00 – 6:30 PM

Networking Reception